In fact, a series of studies showed that these two respective chemokine targets mediate different pathomechanisms of kidney diseases and dual blockade of CCL2 and CXCL12 leads to additive effects on the in prevention of progression of nephropathy and proliferative lupus nephritis.29, 33. This evidence concerns the gene CXCL12 and Nephropathy.